Effect of N-acetylcysteine on serum creatinine and kidney function: Results of a randomized controlled trial

American Journal of Kidney Diseases

Volumn 56, Issue 4, 2010, Pages 643-650

  Moist, Louise ^a   Sontrop, Jessica M ^a   Gallo, Kerri ^a   Mainra, Rahul ^a   Cutler, Murray ^a   Freeman, Dave ^a   House, Andrew A ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

Chronic kidney disease; creatinine clearance; cystatin C, N acetylcysteine; serum creatinine; urine protein

Indexed keywords

ACETYLCYSTEINE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATININE; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; PLACEBO;

ADULT; AGED; ARTICLE; CHEST TIGHTNESS; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; CREATININE URINE LEVEL; DIABETES MELLITUS; DIAGNOSTIC VALUE; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DYSPNEA; FEMALE; GLOMERULONEPHRITIS; HUMAN; HYPERTENSION; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERIPHERAL VASCULAR DISEASE; PROTEIN URINE LEVEL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; TREATMENT DURATION; TREATMENT OUTCOME; URINALYSIS; URINARY EXCRETION; BLOOD; COMPARATIVE STUDY; CONFIDENCE INTERVAL; DOSE RESPONSE; DRUG ADMINISTRATION; FOLLOW UP; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TEST; MIDDLE AGED; NONPARAMETRIC TEST; ORAL DRUG ADMINISTRATION; REFERENCE VALUE; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

ACETYLCYSTEINE; ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; CONFIDENCE INTERVALS; CREATININE; CYSTATIN C; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; REFERENCE VALUES; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC; TREATMENT OUTCOME;

EID: 77956928795     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.03.028     Document Type: Article

References (30)

1. C. Briguori, and G. Marenzi Contrast-induced nephropathy: pharmacological prophylaxis Kidney Int Suppl 100 2006 S30 S38
2. M. Tepel, G.M. van der, and C. Schwarzfeld Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine N Engl J Med 343 3 2000 180 184
3. N. Pannu, B. Manns, H. Lee, and M. Tonelli Systematic review of the impact of N-acetylcysteine on contrast nephropathy Kidney Int 65 4 2004 1366 1374
4. S. Efrati, V. Dishy, and M. Averbukh The effect of N-acetylcysteine on renal function, nitric oxide, and oxidative stress after angiography Kidney Int 64 6 2003 2182 2187
5. N. Nitescu, S.E. Ricksten, and N. Marcussen N-Acetylcysteine attenuates kidney injury in rats subjected to renal ischaemia-reperfusion Nephrol Dial Transplant 21 5 2006 1240 1247
6. M. de Araujo, L. Andrade, T.M. Coimbra, A.C. Rodrigues Jr, and A.C. Seguro Magnesium supplementation combined with N-acetylcysteine protects against postischemic acute renal failure J Am Soc Nephrol 16 11 2005 3339 3349
7. M.H. Shimizu, A. Danilovic, and L. Andrade N-Acetylcysteine protects against renal injury following bilateral ureteral obstruction Nephrol Dial Transplant 23 10 2008 3067 3073
8. J. Kay, W.H. Chow, and T.M. Chan Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial JAMA 289 5 2003 553 558
9. K.G. Shyu, J.J. Cheng, and P. Kuan Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure J Am Coll Cardiol 40 8 2002 1383 1388
10. U. Hoffmann, M. Fischereder, B. Kruger, W. Drobnik, and B.K. Kramer The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable J Am Soc Nephrol 15 2 2004 407 410
11. J.H. Bauer, C.S. Brooks, and R.N. Burch Clinical appraisal of creatinine clearance as a measurement of glomerular filtration rate Am J Kidney Dis 2 3 1982 337 346
12. M. Walser, H.H. Drew, and J.L. Guldan Prediction of glomerular filtration rate from serum creatinine concentration in advanced chronic renal failure Kidney Int 44 5 1993 1145 1148
13. M. Walser Assessing renal function from creatinine measurements in adults with chronic renal failure Am J Kidney Dis 32 1 1998 23 31
14. O. Toprak Interactions between serum creatinine, volume status, N-acetylcysteine, and contrast-induced nephropathy Ren Fail 28 3 2006 265 266
15. R. Mainra, K. Gallo, and L. Moist Effect of N-acetylcysteine on renal function in patients with chronic kidney disease Nephrology (Carlton) 12 5 2007 510 513
16. T. Rehman, J. Fought, and R. Solomon N-Acetylcysteine effect on serum creatinine and cystatin C levels in CKD patients Clin J Am Soc Nephrol 3 6 2008 1610 1614
17. A. Levin, G.E. Pate, and S. Shalansky N-Acetylcysteine reduces urinary albumin excretion following contrast administration: evidence of biological effect Nephrol Dial Transplant 22 9 2007 2520 2524
18. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1 1976 31 41
19. G.R. Hervey Determination of creatinine by the Jaffe reaction Nature 171 4364 1953 1125
20. S.M. Bagshaw, and W.A. Ghali Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: a systematic review and meta-analysis BMC Med 2 2004 38 49
21. M. Haase, A. Haase-Fielitz, and S. Ratnaike N-Acetylcysteine does not artifactually lower plasma creatinine concentration Nephrol Dial Transplant 23 5 2008 1581 1587
22. H. Izzedine, V. Guerin, V. Launay-Vacher, M. Bernard, and G. Deray Effect of N-acetylcysteine on serum creatinine level Nephrol Dial Transplant 16 7 2001 1514-151
23. D.A. Gonzales, K.J. Norsworthy, and S.J. Kern A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity BMC Med 5 2007 32 44
24. S. Genet, R.K. Kale, and N.Z. Baquer Effects of free radicals on cytosolic creatine kinase activities and protection by antioxidant enzymes and sulfhydryl compounds Mol Cell Biochem 210 1-2 2000 23 28
25. R.D. Toto Microalbuminuria: definition, detection, and clinical significance J Clin Hypertens (Greenwich) 6 11 suppl 3 2004 2 7
26. K.R. Tuttle Cardiovascular implications of albuminuria J Clin Hypertens (Greenwich) 6 11 suppl 3 2004 13 17
27. M. Renke, L. Tylicki, and P. Rutkowski The effect of N-acetylcysteine on proteinuria and markers of tubular injury in non-diabetic patients with chronic kidney disease A placebo-controlled, randomized, open, cross-over study Kidney Blood Press Res 31 6 2008 404 410
28. R.L. Eisenberg, W.O. Bank, and M.W. Hedgock Renal failure after major angiography can be avoided with hydration AJR Am J Roentgenol 136 5 1981 859 861
29. G.J. Merten, W.P. Burgess, and L.V. Gray Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial JAMA 291 19 2004 2328 2334
30. S.D. Navaneethan, S. Singh, S. Appasamy, R.E. Wing, and A.R. Sehgal Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis Am J Kidney Dis 53 4 2009 617 627